Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma—A Systematic Review
Open Access
- 16 March 2022
- Vol. 14 (6), 1520
- https://doi.org/10.3390/cancers14061520
Abstract
Beyond laboratory, imaging and endoscopic procedures, new diagnostic tools are increasingly being sought for the diagnosis of upper urinary tract urothelial carcinoma (UTUC), especially those that are non-invasive. In this systematic review, we aimed to determine the effectiveness of non-invasive tests in the diagnosis of UTUC. PubMed and Embase electronic databases were searched to identify studies assessing effectiveness of non-invasive tests in the primary diagnosis of UTUC. The study protocol was registered with PROSPERO (CRD42020216480). Among 10,084 screened publications, 25 were eligible and included in the analysis. Most of them were conducted on small samples of patients and the control groups were heterogenous. The test used in the largest number of studies was voided urinary cytology, which has poor sensitivity (11–71.1%) with favorable specificity (54–100%). Fluorescence in situ hybridization in diagnostic cytology showed higher sensitivity (35–85.7%) with equally good specificity (80–100%). There were also studies on the use of tests known to diagnose bladder cancer such as NMP22, uCYT or BTA test. Other urine or blood tests have been the subject of only isolated studies, with varying results. To conclude, currently there is a lack of high-quality data that could confirm good effectiveness of non-invasive tests used in the diagnosis of UTUC.This publication has 46 references indexed in Scilit:
- Diagnostic Value of the Nuclear Matrix Protein 22 Test and Urine Cytology in Upper Tract Urothelial TumorsUrologia Internationalis, 2011
- Utility of a Modality Combining FISH and Cytology in Upper Tract Urothelial Carcinoma Detection in Voided Urine Samples of Chinese PatientsUrology, 2011
- Evaluation of upper urinary tract tumors by FISH in Chinese patientsCancer Genetics and Cytogenetics, 2010
- Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine SamplesClinical Cancer Research, 2010
- Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005BJU International, 2010
- Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinomaCancer Genetics and Cytogenetics, 2009
- Is There a Role for FISH in the Management and Surveillance of Patients with Upper Tract Transitional-Cell Carcinoma?Journal of Endourology, 2008
- Fluorescence In Situ Hybridization for Detecting Upper Urinary Tract Tumors—A Preliminary ReportUrology, 2007
- Evaluation of the bard BTA-test in the diagnosis of upper urinary tract tumorsActa chirurgica Iugoslavica, 2007